On Friday, Baxter International Inc. (NYSE: BAX) opened lower -2.07% from the last session, before settling in for the closing price of $36.73. Price fluctuations for BAX have ranged from $31.75 to $44.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.04%. Company’s average yearly earnings per share was noted 13.34% at the time writing. With a float of $506.36 million, this company’s outstanding shares have now reached $507.63 million.
Let’s determine the extent of company efficiency that accounts for 60000 employees. In terms of profitability, gross margin is 35.51%, operating margin of 6.37%, and the pretax margin is -0.5%.
Baxter International Inc. (BAX) Insider Activity
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Baxter International Inc. is 0.75%, while institutional ownership is 91.93%. The most recent insider transaction that took place on Sep 16 ’24, was worth 39,046. Before that another transaction happened on Sep 13 ’24, when Company’s Officer proposed sale 16,063 for $39.81, making the entire transaction worth $639,465.
Baxter International Inc. (BAX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 0.68 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.67) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.34% per share during the next fiscal year.
Baxter International Inc. (NYSE: BAX) Trading Performance Indicators
Check out the current performance indicators for Baxter International Inc. (BAX). In the past quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.22. Likewise, its price to free cash flow for the trailing twelve months is 35.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.78 in the next quarter and is forecasted to reach 3.02 in one year’s time.
Technical Analysis of Baxter International Inc. (BAX)
Looking closely at Baxter International Inc. (NYSE: BAX), its last 5-days average volume was 2.04 million, which is a drop from its year-to-date volume of 4.08 million. As of the previous 9 days, the stock’s Stochastic %D was 28.38%. Additionally, its Average True Range was 0.83.
During the past 100 days, Baxter International Inc.’s (BAX) raw stochastic average was set at 43.57%, which indicates a significant increase from 5.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.80% in the past 14 days, which was lower than the 28.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.64, while its 200-day Moving Average is $37.86. However, in the short run, Baxter International Inc.’s stock first resistance to watch stands at $36.55. Second resistance stands at $37.14. The third major resistance level sits at $37.49. If the price goes on to break the first support level at $35.61, it is likely to go to the next support level at $35.26. Should the price break the second support level, the third support level stands at $34.67.
Baxter International Inc. (NYSE: BAX) Key Stats
There are currently 509,580K shares outstanding in the company with a market cap of 18.35 billion. Presently, the company’s annual sales total 14,813 M according to its annual income of 2,656 M. Last quarter, the company’s sales amounted to 3,812 M and its income totaled -314,000 K.
